Sartorius Stedim (UK) Insiders

0RG8 Stock   190.60  2.30  1.19%   
Sartorius Stedim employs about 10 K people. The company is managed by 9 executives with a total tenure of roughly 23243 years, averaging almost 2582.0 years of service per executive, having 1106.78 employees per reported executive. Breaking down Sartorius Stedim's management performance can provide insight into the firm performance.
Rene Faber  CEO
CEO DIrector
Joachim Kreuzburg  Chairman
Chairman CEO
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Sartorius Stedim Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Sartorius Stedim Management Team Effectiveness

The company has return on total asset (ROA) of 0.0319 % which means that it generated a profit of $0.0319 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0525 %, meaning that it generated $0.0525 on every $100 dollars invested by stockholders. Sartorius Stedim's management efficiency ratios could be used to measure how well Sartorius Stedim manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Sartorius Stedim's Other Assets are comparatively stable compared to the past year. Other Current Assets is likely to gain to about 114.5 M in 2025, whereas Total Assets are likely to drop slightly above 2 B in 2025.

Sartorius Stedim Quarterly Income Before Tax

209.5 Million

Net Income Applicable To Common Shares is likely to gain to about 1.1 B in 2025

Sartorius Stedim Workforce Comparison

Sartorius Stedim Biotech is rated fourth in number of employees category among its peers. The total workforce of Industrials industry is presently estimated at about 154,562. Sartorius Stedim holds roughly 9,961 in number of employees claiming about 6% of equities under Industrials industry.
The company has Profit Margin (PM) of 0.07 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.19 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.19.

Sartorius Stedim Biotech Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Sartorius Stedim Biotech Price Series Summation is a cross summation of Sartorius Stedim price series and its benchmark/peer.

Sartorius Stedim Notable Stakeholders

A Sartorius Stedim stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Sartorius Stedim often face trade-offs trying to please all of them. Sartorius Stedim's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Sartorius Stedim's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.

About Sartorius Stedim Management Performance

The success or failure of an entity such as Sartorius Stedim Biotech often depends on how effective the management is. Sartorius Stedim management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Sartorius management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Sartorius management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Sartorius Stedim is entity of United Kingdom. It is traded as Stock on LSE exchange.
Please note, the imprecision that can be found in Sartorius Stedim's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Sartorius Stedim Biotech. Check Sartorius Stedim's Beneish M Score to see the likelihood of Sartorius Stedim's management manipulating its earnings.

Sartorius Stedim Workforce Analysis

Traditionally, organizations such as Sartorius Stedim use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Sartorius Stedim within its industry.

Sartorius Stedim Manpower Efficiency

Return on Sartorius Stedim Manpower

Revenue Per Employee286.9K
Revenue Per Executive317.5M
Net Income Per Employee31.1K
Net Income Per Executive34.4M

Additional Tools for Sartorius Stock Analysis

When running Sartorius Stedim's price analysis, check to measure Sartorius Stedim's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sartorius Stedim is operating at the current time. Most of Sartorius Stedim's value examination focuses on studying past and present price action to predict the probability of Sartorius Stedim's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sartorius Stedim's price. Additionally, you may evaluate how the addition of Sartorius Stedim to your portfolios can decrease your overall portfolio volatility.